MATCH Arm EAY131-Q

**Semantic type:** Intellectual Product

**Definition:** The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with ado-trastuzumab emtansine in patients with cancers that have ERBB2 (HER2) gene amplifications, excluding breast cancers, colorectal cancers, gastric cancers and gastroesophageal junction (GEJ) cancers.

**Synonyms:** - EAY131-Q - Q